Bnp Paribas Viatris Inc Transaction History
Bnp Paribas
- $2.41 Trillion
- Q3 2024
A detailed history of Bnp Paribas transactions in Viatris Inc stock. As of the latest transaction made, Bnp Paribas holds 4,330 shares of VTRS stock, worth $57,242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,330
Previous 1,956
121.37%
Holding current value
$57,242
Previous $20.8 Million
141.78%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VTRS
# of Institutions
1,103Shares Held
934MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.86 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.23 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$834 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$828 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$645 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $16B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...